PATENT CLAIM ANALYSIS

Application Number: 16041646
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["315", "307000"]

Abstract:
The technology relates in part to methods and compositions for ex vivo proliferation and expansion of epithelial cells.

Claim (Index 2):
The method of  claim 1 , wherein the originating epithelial cell population is capable of 25 population doublings or more when cultured under the expansion culture conditions; and the originating epithelial cell population is capable of no more than 20 population doublings when cultured under control culture conditions that do not include the one or more agents that activate telomerase reverse transcriptase in the population and/or inhibit transforming growth factor beta (TGF-beta) signaling.

Metadata:
- Claim Count in Document: 63.0
- Percentile: 95.0
- Lexical Diversity: 1.05556
- Patent Class: 315.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15258751', '15685853', '15296831', '15296920', '15722327']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8471428031348794
- 35 USC 102 Novelty (BERT): 0.7994700308997832
- Combined Prediction Score: 0.8423755259113699
- Mean Citation Score: 854.0567619999997
- Max Citation Score: 987.98376
- Similarity Product: 985.3951427871036

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test